1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3, randomized trial (CheckMate 017) of nivolumab (NIVO) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Reckamp, K.; Brahmer, J. R.; Spigel, D. R.; Rizvi, N. A.; Poddubskaya, E.; West, H.; Eberhardt, W. E. E.; Baas, P.; Antonia, S. J.; Pluzanski, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Longer-term follow-up of a phase 2 study (CheckMate 063) of nivolumab in patients with advanced, refractory squamous non-small cell lung cancer
    Meeting Abstract

    Horn, L.; Rizvi, N. A.; Mazières, J.; Planchard, D.; Stinchcombe, T. E.; Dy, G. K.; Antonia, S. J.; Léna, H.; Minenza, E.; Mennecier, B.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted ADC, rovalpituzumab tesirine, demonstrates substantial activity in a phase I study in relapsed and refractory SCLC
    Meeting Abstract

    Rudin, C. M.; Pietanza, M. C.; Spigel, D. R.; Bauer, T. M.; Glisson, B.; Robert, F.; Ready, N.; Morgensztern, D.; Kochendoerfer, M. D.; Patel, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Spatiotemporal effects on programmed death ligand 1 (PD-L1) expression and immunophenotype of non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kowanetz, M.; Koeppen, H.; Boe, M.; Chaft, J. E.; Rudin, C. M.; Zou, W.; Nickles, D.; Desai, R.; Nakamura, R.; Sandler, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Chung, S. S.; Park, C. Y.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • RhoA activation in diffuse type gastric adenocarcinoma promotes cancer stem cell phenotypes including chemotherapy resistance
    Meeting Abstract

    Yoon, C.; Cho, S. J.; Aksoy, B. A.; Park, D. J.; Yoon, S. S.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • CHRONOS-3: A phase III, randomized, double-blind, placebocontrolled study evaluating the efficacy and safety of phosphatidylinositol-3 kinase (PI3K) alpha/delta inhibitor copanlisib in combination with rituximab in patients with relapsed indolent B-c
    Meeting Abstract

    Zinzani, P. L.; Gerecitano, J. F.; Giurescu, M.; Ito, R.; Mueller, K.; Childs, B. H.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Tumor-specific regulation of receptor tyrosine kinases by Grp94
    Meeting Abstract

    Yan, P.; Patel, H.; Patel, P.; Ochiana, S.; Sun, W. L.; Shah, S.; Finotti, P.; Leifer, C.; Li, Z. H.; Gewirth, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save